Glenmark Pharma’s Shares Surge as Unit bags Licensing pact to sell Cancer Drugs
Glenmark Pharmaceuticals shares climbed more than 2% in the early trading hours on Thursday after the pharma company announced that its subsidiary, Glenmark Specialty S...